BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• 

  Biotech Bay

  Spruce Biosciences Closes on $88 Million Series B Round, Advancing CAH Program

  Spruce intends to use the funds raised to evaluate tildacerfont to reduce glucocorticoid steroid usage in adults with CAH, and to complete proof-of-concept trials in children.

  February 20, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  Consumer Groups, Unions Petition to Block Merger of Allergan and AbbVie

  A group of unions and consumer organizations have banded together in opposition to the $63 billion merger citing concerns that it will create a monopoly and harm competition.

  February 20, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Immatics and GSK Team Up to Develop and Advance T-Cell Therapies

  Immatics is eligible for more than $550 million in various commercial milestone payments for each product as well as additional royalties.

  February 20, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  BioCapital

  Research Roundup: Misfolding DNA and Type 1 Diabetes and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  February 20, 2020

   · 

  5 min read

   · 

  Mark Terry
• 

  Business

  A Look at Kazia’s Business Model with CEO James Garner

  Kazia Therapeutics is company focused on developing anti-cancer drugs.

  February 20, 2020

   · 

  2 min read

   · 

  Gina Hagler
• 

  Do You Have Imposter Syndrome? 7 Ways to Overcome It

  Learning to love and accept your authentic self will go a long way toward quashing Imposter Syndrome.

  February 20, 2020

   · 

  3 min read

   · 

  Katharine Hansen, PhD
• 

  Business

  BioSpace Movers & Shakers, Feb. 21

  Biopharma and life sciences companies strengthen their leadership teams and board with this week’s Movers & Shakers.

  February 20, 2020

   · 

  6 min read

   · 

  Alex Keown
• 

  FDA

  FDA Action Alert: GBT’s Oxbryta and BeiGene’s Brukinsa

  Here’s a look at the two drugs that had dates this week but were approved early and are now on the market.

  February 20, 2020

   · 

  3 min read

   · 

  Mark Terry
• Business

  Vifor Pharma and Fresenius Kabi create joint venture in China for i.v. iron portfolio

  Partnership brings together Vifor Pharma’s world-class iron deficiency portfolio with Fresenius Kabi’s market-leading patient access in China

  February 20, 2020

   · 

  4 min read
• Biotech Bay

  Breath Therapeutics, a Zambon company, initiates BOSTON-3 and BOSTON-4, two additional clinical studies for the treatment of bronchiolitis obliterans syndrome (BOS)

  Liposomal Cyclosporine A for Inhalation (L‑CsA‑i) is advancing in clinical studies for the treatment for bronchiolitis obliterans syndrome (BOS)

  February 20, 2020

   · 

  7 min read